4
Changes in Ownership
NEUROCRINE BIOSCIENCES INC Filed Acc 0001209191-20-007686
Chief Regulatory Officer sold 3,438 shares at an average $102.38 ($351,991)
From the SEC's structured data for this filing
Trades in this filing
Lloyd-Smith Malcolm · Chief Regulatory Officer
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2020-02-05 | Sale : show line 1 in the form | −1,083 | $103.03 | $111,586 | 20,455 | D |
| 2020-02-05 | Sale : show line 2 in the form | −865 | $103.06 | $89,146 | 21,127 | D |
| 2020-02-06 | Sale : show line 3 in the form | −1,490 | $101.52 | $151,258 | 22,287 | D |
| Open-market sales · 3,438 sh · avg $102.38 · $351,991 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2020-02-06 | Grant or award : show line 4 in the form Stock Option | +38,342 | $102.90 | 2030-02-06 | 38,342 | 38,342 | D |
| 2020-02-06 | Grant or award : show line 5 in the form Restricted Stock Unit | +6,074 | 6,074 | 6,074 | D |
Loading xslF345X03/doc4.xml…